Aktie EUCI EUROCINE VACCINES AB
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Eurocine Vaccines AB

Aktien

EUCI

SE0015382155

EUCI

Schlusskurs NORDIC GROWTH MARKET
Andere Börsenplätze
 00:00:00 31.05.2024 		% 5 Tage % 1. Jan.
0.04 SEK +16.96% Intraday Chart für Eurocine Vaccines AB -13.04% -13.04%
28.02. Eurocine Vaccines AB (publ) meldet Ergebnis für das zweite Quartal und die sechs Monate bis zum 31. Dezember 2023 CI
2023 Eurocine Vaccines AB (publ) meldet Ergebnis für das erste Quartal bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Eurocine Vaccines AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
Eurocine Vaccines AB Reports Earnings Results for the First Quarter Ended September 30, 2023
Eurocine Vaccines AB Reports Earnings Results for the Fourth Quarter Ended June 30, 2023
Eurocine Vaccines AB Reports Earnings Results for the Full Year Ended June 30, 2023
Eurocine Vaccines AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023
Eurocine Vaccines AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2022
Eurocine Vaccines AB Decides to Develop mRNA-Based Vaccine Candidate Against Chlamydia
Eurocine Vaccines AB Reports Earnings Results for the First Quarter Ended September 30, 2022
Eurocine Vaccines AB Reports Earnings Results for the Full Year Ended June 30, 2022
Eurocine Vaccines AB Reports Earnings Results for the Fourth Quarter Ended June 30, 2022
Eurocine Vaccines AB Enters into Research and Collaboration Agreement with Redbiotec AG
Eurocine Vaccines AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2022
Eurocine Vaccines AB Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2021
Eurocine Vaccines Resolves on Scientific Advice with Swedish Medical Products Agency ahead of Clinical Trial Application
Eurocine Vaccines AB Reports Earnings Results for the First Quarter Ended September 30, 2021
Eurocine Vaccines AB Announces Earnings Results for the Quarter and Full Year Ended June 30, 2021
Eurocine Vaccines AB Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2021
Eurocine Vaccines AB Announces Earnings Results for the Half-Year Ended December 2020
Eurocine Vaccines AB Reports Group Earnings Results for the First Quarter Ended September 30, 2020
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. EUCI Aktie
  4. Nachrichten Eurocine Vaccines AB
  5. Andere Sprachen